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Mercury has been identified as one of the
most serious environmental threats to the
well-being of wildlife in the southeastern
United States (Facemire et al. 1995). The
prevalence of Hg in aquatic species has also
prompted concerns for the health of subsis-
tence ﬁshermen and the general population
who regularly consume ﬁsh. This concern is
evident in the fact that 76% of fish con-
sumption advisories in the United States in
2003 were due at least in part to Hg, for a
total of 5,289,020 hectares of lakes and
1,234,127 river miles [U.S. Environmental
Protection Agency (EPA) 2004]. The toxic
effects of Hg have been demonstrated in
mammals, birds, and ﬁsh and include neuro-
toxicity, impaired growth and development,
reduced reproductive success, liver and kid-
ney damage, and immunomodulation
(Wiener et al. 2003; Zelikoff et al. 1994).
Reptiles are prominent members of
ecosystems and often have life history charac-
teristics that make them vulnerable to Hg
accumulation (e.g., long life span, high
trophic level, aquatic habitat). Despite the fact
that many of these reptilian species also have a
tenuous conservation status, there are cur-
rently few data on the toxicity of Hg in this
taxon. One such example is the sea turtle, of
which all species are classiﬁed as either threat-
ened or endangered. Many anthropogenic
factors have been implicated in the decline
in sea turtle populations, including directed
harvest for food and trade, ﬁsheries bycatch,
and degradation of nesting beach habitat
(Lutcavage et al. 1997). However, the role of
chemical pollutants in marine turtle health is
largely unknown. It is therefore important to
understand the risk that contaminants pose to
the general health and immunologic function
of sea turtles because these effects could also
impact the survival of their populations.
Several studies have measured Hg levels
in tissues from juvenile and adult sea turtles
(Anan et al. 2001; Davenport and Wrench
1990; Day et al. 2005; Godley et al. 1999;
Gordon et al. 1998; Maffucci et al. 2005;
Orvik 1997; Presti 1999; Sakai et al. 1995,
2000a, 2000b; Storelli et al. 1998, 2005;
Wang 2005). However, relatively few studies
have assessed health parameters in sea turtles
in relation to environmental contaminants
(Keller et al. 2004, 2005, 2006a, 2006b;
Lutcavage et al. 1995; Peden-Adams et al.
2002, 2003; Podreka et al. 1998), and these
studies have focused primarily on organic
contaminants rather than metals. Balazs and
Pooley (1991) suggested that environmental
contaminants are a possible factor contribut-
ing to the development of the viral disease
ﬁbropapillomatosis in sea turtles by reducing
immune function. Some locations in Florida
(Indian River Lagoon and Florida Bay)
exhibit up to 70% prevalence of this disease,
and these environments also have elevated lev-
els of Hg (Ache et al. 2000; Cantillo et al.
1999; Trocine and Trefry 1996). In the pre-
sent study we investigated the relationship of
blood Hg levels in loggerhead sea turtles
(Caretta caretta) off the coasts of South
Carolina, Georgia, and northern Florida to
various immunologic and general health para-
meters. Using an integrated approach, correla-
tive field data collection from wild-caught
loggerhead sea turtles were combined with
laboratory in vitro exposure of loggerhead
lymphocytes to methylmercury (MeHg).
Material and Methods
Sample collection and processing. Free-ranging
subadult and adult loggerhead sea turtles
with straight carapace lengths (measured
from the nuchal notch to the most posterior
marginal notch) between 51.4 and 94.9 cm
Environmental Health Perspectives • VOLUME 115 | NUMBER 10 | October 2007 1421
Research
Address correspondence to R.D. Day, NIST, Hollings
Marine Laboratory, 331 Ft. Johnson Rd., Charleston,
SC 29412 USA. Telephone: (843) 762-8904. Fax:
(843) 762-8742. E-mail: russell.day@nist.gov
We thank J.D. Whitaker and P. Maier for collecting
the samples from turtles; J.G. EuDaly, S.O. Martin,
L.M. Heesemann, and D.E. Keil for laboratory assis-
tance; and D. Owens for sex determination (plasma
testosterone) and corticosterone. 
This work was partially funded by a grant to J.D.W.
from the National Marine Fisheries Service
(NA07FL0499). This work constitutes Scientific
Contribution Number 160 from the Sea Research
Foundation Inc.
Certain commercial equipment or instruments are
identified in the article to specify adequately the
experimental procedures; such identification does
not imply recommendations or endorsement by the
National Institute of Standards and Technology, nor
does it imply that the equipment or instruments are
the best available for the purpose.
The authors declare they have no competing
ﬁnancial interests.
Received 22 November 2006; accepted 11 July 2007.
Relationship of Blood Mercury Levels to Health Parameters in the
Loggerhead Sea Turtle (Caretta caretta)
Rusty D. Day,1,2 Al L. Segars,2,3 Michael D. Arendt,3 A. Michelle Lee,2,4 and Margie M. Peden-Adams2,4,5,6
1National Institute of Standards and Technology, Hollings Marine Laboratory, Charleston, South Carolina, USA; 2College of Charleston,
Grice Marine Laboratory, Charleston, South Carolina, USA; 3South Carolina Department of Natural Resources, Marine Resources Division,
Charleston, South Carolina, USA; 4Department of Pediatrics, and 5Marine Biomedicine and Environmental Science Center, Medical
University of South Carolina, Charleston, South Carolina, USA; 6Mystic Aquarium and Institute for Exploration, Mystic, Connecticut, USA
BACKGROUND: Mercury is a pervasive environmental pollutant whose toxic effects have not been
studied in sea turtles in spite of their threatened status and evidence of immunosuppression in
diseased populations.
OBJECTIVES: In the present study we investigate mercury toxicity in loggerhead sea turtles (Caretta
caretta) by examining trends between blood mercury concentrations and various health parameters.
METHODS: Blood was collected from free-ranging turtles, and correlations between blood mercury
concentrations and plasma chemistries, complete blood counts, lysozyme, and lymphocyte
proliferation were examined. Lymphocytes were also harvested from free-ranging turtles and
exposed in vitro to methylmercury to assess proliferative responses.
RESULTS: Blood mercury concentrations were positively correlated with hematocrit and creatine
phosphokinase activity, and negatively correlated with lymphocyte cell counts and aspartate amino-
transferase. Ex vivo negative correlations between blood mercury concentrations and B-cell
proliferation were observed in 2001 and 2003 under optimal assay conditions. In vitro exposure of
peripheral blood leukocytes to methylmercury resulted in suppression of proliferative responses for
B cells (0.1 µg/g and 0.35 µg/g) and T cells (0.7 µg/g). 
CONCLUSIONS: The positive correlation between blood mercury concentration and hematocrit reﬂects
the higher afﬁnity of mercury species for erythrocytes than plasma, and demonstrates the importance
of measuring hematocrit when analyzing whole blood for mercury. In vitro immunosuppression
occurred at methylmercury concentrations that correspond to approximately 5% of the individuals
captured in the wild. This observation and the negative correlation found ex vivo between mercury
and lymphocyte numbers and mercury and B-cell proliferative responses suggests that subtle negative
impacts of mercury on sea turtle immune function are possible at concentrations observed in the wild.
KEY WORDS: aspartate aminotransferase (AST), blood, creatine phosphokinase (CPK), hematocrit,
immunotoxicity, lymphocytes, loggerhead sea turtles, mercury, methylmercury, toxicity. Environ
Health Perspect 115:1421–1428 (2007). doi:10.1289/ehp.9918 available via http://dx.doi.org/
[Online 11 July 2007]were captured as part of a sea turtle index-of-
abundance study conducted by the South
Carolina Department of Natural Resources
(National Marine Fisheries Service Scientiﬁc
Research Permit No. 1245). All samples for
the present study were collected in 2001 and
2003 between the last week in May and the
last week in July. Turtles were captured using
20.3-cm stretch mesh trawl nets without tur-
tle excluder devices and a trawl tow time of
30 min. Approximately 750 trawl stations
were randomly selected each year and sam-
pled from a sampling “universe” represent-
ing every 1 square nautical mile in water
depths of 4.8–14.9 m between Winyah Bay,
South Carolina, and St. Augustine, Florida
(Figure 1). Turtles were tagged, measured,
weighed, and released near their capture loca-
tion. Blood was collected from the dorso-
cervical sinus using double-ended Vacutainer
needles directly into heparinized Vacutainer
blood collection tubes (BD, Franklin Lakes,
NJ) and kept cool until processing. Samples
for blood chemistry panels, differential white
blood cell (WBC) counts, and lymphocyte
proliferation were analyzed within 36 hr of
collection; samples for plasma lysozyme activ-
ity and Hg determination were stored at
–20°C until analysis. All animals in this study
were treated humanely and with regard for
alleviation of suffering.
Total Hg analysis. We determined total
Hg (THg) concentration (based on wet mass)
in tissues using isotope dilution cold vapor
inductively coupled plasma mass spectrometry
(ICPMS) at the National Institute of
Standards and Technology (NIST, Hollings
Marine Laboratory, Charleston, SC). This
analytical method has been previously
described in detail (Christopher et al. 2001).
Brieﬂy, isotopically enriched 201Hg spike solu-
tion was prepared and calibrated using NIST
Standard Reference Material (SRM) 3133 Hg
Spectrometric Solution. The spike was then
added quantitatively to approximately 0.8 g
blood to yield an isotopic ratio (201Hg/202Hg)
that minimizes random error propagation.
Samples were then digested and equilibrated
in a PerkinElmer Multiwave microwave oven
(PerkinElmer, Shelton, CT) at the highest
possible temperatures (up to 300°C) and pres-
sures (up to 8 MPa) using quartz microwave
decomposition vessels and high-purity nitric
acid (Fisher Scientific, Suwanee, GA). The
digestant was mixed with a tin chloride and
hydrochloric acid reductant solution in a gas–
liquid separator, allowing cold vapor transfer
of the resulting Hg0 in a stream of argon to
the ICPMS injector. We used a Plasma Quad
3 ICPMS (VG Elemental, Windsford,
Cheshire, UK) using typical ICP power and
gas ﬂows in time-resolved analysis mode for
measurement of isotopic ratios.
Clinical chemistry and complete blood
counts. Blood samples were collected for
plasma chemistry and complete blood count
(CBC) analysis (according to the contract
laboratory’s specifications) and were
shipped overnight on cold packs to Antech
Diagnostics (Memphis, TN) for a complete
reptilian profile according to their “test
express” option so that all samples were ana-
lyzed by the same laboratory, and theoreti-
cally, by the same technician. Therefore
6 samples collected in 2001 were combined
with 22 samples from 2003 for statistical
analysis. Samples for clinical chemistries were
collected in heparinized serum separator
microtainers and CBC analyses, including
WBC differentials and estimated WBC
counts, were conducted on blood smears
from heparinized whole blood.
Lymphocyte proliferation: ex vivo THg
exposure. The proliferative response was meas-
ured using optimized methods described by
Keller et al. (2005, 2006a). Brieﬂy, peripheral
blood leukocytes (PBLs) were isolated by a
slow spin technique within 36 hr of blood
collection. Cells were rinsed once with
RPMI 1640 media (Mediatech Inc.,
Herndon, VA) that was supplemented with
5% fetal bovine serum (FBS; Hyclone, Logan,
UT, in 2001; Gemini, Calabasas, CA, in
2003), and ﬁnal concentrations of 1% (vol-
ume fraction) of 100x solution of nonessential
amino acids (Gibco, Grand Island, NY),
1 mmol sodium pyruvate (Gibco), 10 mmol
HEPES (Mediatech Inc.), 50 IU/mL peni-
cillin (Mediatech Inc.), and 50 µg/mL strep-
tomycin (Mediatech Inc.), which was initially
brought to a pH of 6.9. The change in FBS
source was shown in paired samples in 2003
to not alter the lymphocyte proliferation
response (Keller et al. 2005). Viable PBLs
were counted by trypan blue exclusion and
diluted to 1.8 × 106 cells/mL in the supple-
mented RPMI 1640 medium. Aliquots
(100 µL) of the resulting cell suspensions were
dispensed into 96-well plates (1.8 × 105
cells/well) containing triplicate wells of either
20 µg/mL concanavalin A (Con A, type IV-S;
Sigma Chemical Co., St. Louis, MO),
5 µg/mL phytohemagglutinin (PHA; L9132;
Sigma), 10 µg/mL lipopolysaccharide (LPS;
E. coli 0111:B4; Sigma), 0.2 µg/mL,
phorbol 12,13-dibutyrate (PDB; Sigma), or
supplemented RPMI 1640 (unstimulated
control wells). All mitogen concentrations
are expressed in micrograms per milliliter of
culture (final culture concentration; culture
volume was 200 µL).
Cells were incubated at 30°C with 5%
CO2 for 96 hr (LPS and PDB in 2001 and
2003) or 120 hr (Con A and PHA in 2001
and 2003; LPS and PDB in 2001).
Following either the 96-hr or the 120-hr ini-
tial incubation, 0.5 µCi 3H-thymidine (ICN
Biomedicals Inc., Irvine, CA) was added to
each well in a volume of 100 µL. Plates were
further incubated for 16 hr and then har-
vested onto Unifilter plates (Packard,
Meridian, CT) using a Packard Filtermate
96-well plate harvestor, and the plates were
allowed to dry. Once the plates were dry, a
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Figure 1. Map showing stations where loggerhead sea turtles were captured and sampled for clinical
blood chemistry proﬁles, immune function parameters, or blood mercury concentration.
0 20 40 80 km25-µL aliquot of Microscint 20 (Packard) was
added to each well, and the samples were
analyzed using a Packard Top Count-NXT
scintillation counter. The stimulation index
(SI) was calculated for each sample as the
counts per minute (cpm) of mitogen-stimu-
lated cells divided by the cpm of unstimu-
lated control (media only) cells.
Lymphocyte proliferation: in vitro MeHg
exposure. PBLs from loggerhead turtles cap-
tured and released in the summers of 2003
and 2004 were isolated and diluted as
described above. Cells were plated at 1.8 × 105
cells/well in a final volume of 200 µL/well.
Final mitogen concentrations in the culture
wells were 5 µg/mL PHA 0.2 µg/mL PDB, or
supplemented RPMI 1640 (unstimulated con-
trol wells). MeHg (Sigma) was diluted in ster-
ile tissue culture water (Mediatech Inc.), to a
stock of 0.1 mg/mL, and dilutions of dosing
solutions were made from this stock into sup-
plemented RPMI 1640 media as described
above. MeHg was added in a volume of 5 µL
to yield the appropriate concentrations in a
ﬁnal well volume of 205 µL. The concentra-
tions of MeHg in the culture wells for prolifer-
ation studies were 0, 0.01, 0.03, 0.05, 0.1,
0.35, and 0.7 µg/g. The concentrations of
MeHg in the culture wells for cell viability
studies were 0, 0.01, 0.03, 0.05, 0.1, 0.5, and
1.0 µg/g.
PBLs from individual turtles were
exposed to all concentrations, resulting in a
dose–response relationship for each individ-
ual animal. Cells were incubated at 30°C
with 5% CO2 for 120 hr at which time
3H-thymidine was added; proliferation was
measured 16 hr later as described above
(total incubation, 136 hr). Cell viability was
determined by trypan blue exclusion of cells
from an additional nonstimulated replicate
of each contaminant concentration at time
of harvest (136 hr).
Lysozyme activity. We measured lysozyme
activity using a standard turbidity assay as
previously described by Demers and Bayne
(1997) with slight modiﬁcations. A 1-mg/mL
stock solution of hen egg lysozyme (HEL;
Sigma) was prepared in 0.1 mol/L phosphate
buffer (pH 5.9) and aliquots were frozen
until used. A solution of Micrococcus lysodeik-
ticus (Sigma) was prepared fresh daily by dis-
solving 50 mg of the lyophilized cells in
0.1 mol/L phosphate buffer, pH 5.9
(100 mL). HEL was serially diluted in phos-
phate buffer to produce a standard curve of
40, 20, 10, 5, 2.5, 1.25, 0.6, 0.3, and 0 µg/µL.
Each concentration (25 µL/well) was added to
a 96-well plate in triplicate. For each sample, a
25-µL aliquot of test plasma was added in
quadruplicate to the plate. The solution of M.
lysodeikticus (175 µL/well) was added quickly
to each of the three sample wells and to the
standard wells. To the fourth well containing
plasma, 175 µL phosphate buffer was added as
a blank. Plates were assessed immediately at
450 nm, at time 0 (T0) and again after 5 min
(T5) with a spectrophotometer (Packard).
Absorbance unit values at T5 were subtracted
from those at T0 to determine the change in
absorbance. The absorbance unit value for the
blank sample well was subtracted from the
average of the triplicate sample wells to
account for slight hemolysis in some of the
samples. The resultant absorbance unit value
was converted to micrograms per microliter
HEL using the linear equation from the stan-
dard curve. Lysozyme assays on samples from
2001 and 2003 were performed by two differ-
ent technicians; therefore, these two data sets
were not combined for statistical analysis.
Corticosterone and testosterone. We meas-
ured plasma testosterone and corticosterone
levels using standard radioimmunoassays, with
the same protocol for both steroid hormones.
Following an ether extraction, commercially
available tritiated hormone and steroid anti-
body were added to duplicate samples and
controls. The unbound hormone was sepa-
rated by dextran-coated charcoal in phosphate
buffer. Tritiated hormone in the supernatant
was measured using a liquid scintillation
counter, and RIAMENU software (developed
by Paul Licht; University of California,
Berkeley, CA) was used to determine the
amount of native hormone in the plasma sam-
ples. These assays are sensitive in the range of
tens of picograms to hundreds of nanograms.
Sex determination was based on previous stud-
ies validating testosterone concentrations in
male and female green turtles (Owens 1997).
Statistics. All statistical analyses were per-
formed using JMP 4.02 (SAS Institute Inc.
Cary, NC). No health parameters varied
with either straight carapace length or sex, so
all size classes and sexes were pooled for sta-
tistical analyses. A backward stepwise regres-
sion (n = 28) was run to analyze the
relationship between blood Hg concentra-
tion and hematocrit, glucose, lymphocyte
cell count, heterophil cell count, urea nitro-
gen, total protein, albumin, aspartate amino-
transferase (AST), calcium, phosphorus,
sodium, potassium, chlorine, globulin, crea-
tine phosphokinase (CPK), and uric acid.
The stepwise model used natural log-trans-
formed Hg concentrations and was set to
reject parameters with a signiﬁcance level of
p > 0.1. Relationships between blood Hg
concentrations and ex vivo lymphocyte pro-
liferation, lysozyme, and corticosterone were
determined using the Spearman rho rank
correlation test for the 2003 data set. The
Pearson correlation test was used with log-
transformed Hg concentration and lysozyme
for the preliminary data from 2001 (n = 12).
In vitro MeHg exposures were assessed using
a two-way ANOVA (p < 0.05) with log-
transformed SI, MeHg dose level, and turtle
identification number (to account for vari-
ability in sensitivity and endogenous natural
Hg concentrations among individuals). Each
dose level was compared with the control
using a pair-wise orthogonal t-test. The
in vitro proliferative dose response was
assessed further by regression analysis. The
log transformation of the end point (SI) was
plotted against the log dose. The log dose
needed to achieve 50% suppression of the
immune response was determined from the
regression equation, and the inverse log was
calculated to determine the ED50 (effective
dose to produce a 50% response). 
Results
THg concentrations. The samples from 2003
(n = 66) represent previously unpublished Hg
analyses and range from 0.006 to 0.077 µg/g,
with a mean (± 1 SE) Hg concentration of
0.029 ± 0.002 µg/g. This mean value is
nearly identical to previously published blood
Hg concentrations from loggerheads in the
same region (Table 1). In a previous study
(Day et al. 2005), blood Hg concentrations
ranged from 0.005 to 0.188 µg/g, with a
mean (± 1 SD) of 0.029 ± 0.008 µg/g
(n = 34). The turtles in that study were cap-
tured in 2001 as part of the same sampling
program and, where complementary data
were available, were incorporated into
comparisons to health parameters in the pre-
sent study (Table 1). The consistency of these
blood Hg values over a 3-year period suggests
that these data are very representative of this
population of loggerheads. The most notable
difference in the Hg levels in these two data
Mercury and loggerhead sea turtle health
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Table 1. Sea turtle blood Hg concentrations (µg/g wet mass) in the present study and in previously
published work.
Study Species Location Collection year Mean ± SE (range) No.
Present study Caretta caretta Southeast (USA) 2003 0.029 ± 0.002 (0.006–0.077) 66
(all samples)
Day et al. 2005 Caretta caretta Southeast (USA) 2001 0.029 ± 0.008 (0.005–0.188) 34
Presti 1999 Caretta caretta Texas (USA) 1997 0.014 (0.01–0.017) 3
Presti 1999 Lepidochelys kempi Texas (USA) 1997 0.027 (0.005–0.087) 76
Orvik 1997 Lepidochelys kempi Texas (USA) 1994/1995 0.018 (0.0005–0.067) 106
Wang 2005 Lepidochelys kempi Southeast/Gulf 2000–2002 0.016 ± 0.002 (0.0006–0.179) 106
of Mexico (USA)
Wang 2005 Lepidochelys kempi Rancho Neuvo, 2002 0.069 ± 0.009 (0.013–0.145) 18
Mexicosets is the higher range in the 2001 samples
compared with those from 2003.
Clinical blood parameters. Summary sta-
tistics for blood chemistry and differential
WBC counts (CBC) for these individuals are
presented in Table 2. A comprehensive
account of these parameters from the larger
data set from which this subsample was taken
was published by Maier et al. (2004). In the
present study, all clinical blood parameters
except hematocrit, CPK, lymphocyte cell
count, heterophil cell count, and AST were
rejected from the stepwise regression model
(r2 = 0.54; p = 0.003). We observed a signiﬁ-
cant positive correlation between blood Hg
and hematocrit (p = 0.01; Figure 2A) and
CPK (p = 0.03; Figure 2B), and a negative
correlation between blood Hg and AST
(p = 0.02; Figure 2C). Within the differential
WBC counts, we observed a signiﬁcant nega-
tive correlation between blood Hg concentra-
tion and lymphocyte cell count (p = 0.05;
Figure 2D).
Ex vivo lymphocyte proliferation as a func-
tion of natural THg exposure. A preliminary
study using 12 samples collected during the
summer of 2001 (Day 2003) indicated that
PDB-induced B-cell proliferation was lower in
loggerheads with higher blood Hg concentra-
tions when incubated for 120 hr (Spearman
ρ = –0.685; p = 0.014). Incubation times of
96 hr did not yield signiﬁcant correlations in
2001. When repeated with the larger data set
(n = 58) in 2003, the SI for T-cell and B-cell
proliferation were not signiﬁcantly correlated
with blood Hg concentrations (p > 0.05)
with incubation times of 96 hr. Because of
technical difﬁculties, results from the 120-hr
incubations were not available for the 2003
ex vivo assays. In addition to these planned
ex vivo experiments, the results from another
proxy ex vivo experiment are reported here.
No MeHg dose was added to the control
samples in the in vitro exposure, meaning
that they were incubated for 120 hr with
exposure to only the natural, endogenous Hg
present in the blood. Therefore the in vitro
control group is in essence another ex vivo
proliferation assay. A linear regression
between endogenous blood Hg concentra-
tions and B-cell SI for the nine individuals
for which Hg data were available showed a
highly significant negative correlation
(r2 = 0.80; p = 0.001) (Figure 3). The mean
± SE of SI, sample size, correlation coeffi-
cients, and p-value for these experiments are
reported in Table 3 for each data set.
Lysozyme activity. Assays performed on
samples from 2001 (n = 12) showed a signiﬁ-
cant positive correlation between lysozyme
activity and blood Hg concentrations
(r = 0.63, p = 0.03) (Table 3). This data set
was expanded using samples collected in
2003 (n = 58); however, lysozyme activity
did not exhibit a signiﬁcant relationship with
blood Hg in the second set of experiments
(p > 0.05). The mean absorbance for
lysozyme activity, sample size, correlation
coefficient, and p-value are reported in
Table 3 for each data set.
In vitro proliferation following laboratory
exposure to MeHg. Cell viability was assessed
by trypan blue at the termination of the expo-
sure study. Treatment with 0.5 and 1 µg/g
MeHg resulted in a signiﬁcant decrease in cell
viablity (Figure 4A). Statistical models for
both B-cell and T-cell proliferation were
highly signiﬁcant (p < 0.0001) with r2 = 0.72
and r 2 = 0.74, respectively. The dose level
was a significant factor in both the B-cell
(p < 0.0001) and T-cell (p < 0.01) models, as
was the turtle identification number
(p < 0.0001). B-cell proliferation (PDB-
induced) was suppressed compared with the
control at 0.1 µg/g (p = 0.02) and 0.35 µg/g
(p < 0.0001), and enhanced relative to control
at 0.01 µg/g (p = 0.04) (Figure 4B). The no
observed effect level (NOEL) for suppression
of B-cell proliferation was 0.05 µg/g Hg. The
calculated ED50 for this response was
Day et al.
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Figure 2. Natural log of blood Hg concentration (µg/g) versus clinical blood parameters for loggerhead sea
turtles. Leverage plots from a multiple regression (r2 = 0.54; p = 0.003) show the relationship of blood Hg
levels to hematocrit (A; p = 0.01), CPK (B; p = 0.03), AST (C; p = 0.02), lymphocyte cell count (D; p = 0.05),
and heterophil cell count (E; p = 0.07). Four of the ﬁve health parameters varied signiﬁcantly (p < 0.05) with
blood Hg concentration. No health parameters varied with either age (indicated by straight carapace
length) or sex, so all size classes and sexes were pooled for statistical analysis. 
–2.5
–3.5
–4.5
–5.5
–2.5
–3.0
–3.5
–4.0
–4.5
0 10 20 30 40 50 0 1,500 3,000 4,500
Hematocrit leverage CPK leverage
I
n
 
b
l
o
o
d
 
H
g
 
(
μ
g
/
g
)
–2.5
–3.0
–3.5
–4.0
–4.5
–5.0
AST leverage
0 100 200 300 400 500
Lymphocyte count leverage
0
–2.5
–3.0
–3.5
–4.0
–4.5
–5.0
3,000 6,000 9,000 12,000
Heterophil count leverage
–2.5
–3.0
–3.5
–4.0
–4.5
–5.0
6,000 4,000 2,000 0
A B
C D
E
I
n
 
b
l
o
o
d
 
H
g
 
(
μ
g
/
g
)
I
n
 
b
l
o
o
d
 
H
g
 
(
μ
g
/
g
)
I
n
 
b
l
o
o
d
 
H
g
 
(
μ
g
/
g
)
I
n
 
b
l
o
o
d
 
H
g
 
(
μ
g
/
g
)
Table 2. Summary statistics for clinical blood para-
meters and their relationships to total blood Hg
concentration based on a backward stepwise mul-
tiple regression. 
Parameter Mean ± SE p-Value
Hematocrit (%)a 35.7 ± 1.1 ↑ 0.01
Total protein (g/dL) 5.1 ± 0.2 0.40
Albumin (g/dL) 1.0 ± 0.1 0.66
Globulin (g/dL) 3.0 ± 0.2 0.43
Glucose (mg/dL) 95.0 ± 5.6 0.80
Urea nitrogen (mg/dL) 65.2 ± 5.2 0.59
Uric acid (mg/dL) 1.2 ± 0.1 0.34
AST (U/L)a 203.1 ± 17.3 ↓ 0.02
CPK (U/L)a 1257.2 ± 170.7 ↑ 0.03
Calcium (mg/dL) 7.3 ± 0.2 0.83
Phosphorus (mg/dL) 7.6 ± 0.3 0.93
Sodium (mEq/L) 153.1 ± 1.3 0.94
Potassium (mEq/L) 4.5 ± 0.1 0.84
Chlorine (mEq/L) 113.0 ± 1.8 0.80
Lymphocyte counts (103/µL)a 6,180 ± 662 ↓ 0.05
Heterophil counts (103/µL)a 2,928 ± 230 0.07
Arrows denote a significant relationship (α < 0.05) and
indicate a positive or negative correlation to blood Hg
concentration. The overall model had an r2 = 0.54 and p =
0.003. Hg concentrations in samples used in this analysis
include 6 samples reported by Day et al. (2005) and 22
additional samples from the present study (n = 28). Hg
concentrations ranged from 0.006 µg/g to 0.077 µg/g Hg,
with a mean ± SE of 0.027 µg/g ± 0.003 µg/g Hg.
aParameters with p < 0.1 that were not rejected from the
model.0.08 µg/g (y = 0.9891x3 + 3.5507x2 + 3.1556x
+ 0.2005; r 2 = 0.99). T-cell proliferation
(PHA-induced) was suppressed at concentra-
tions of 0.7 µg/g (p = 0.003; Figure 4C). The
NOEL for T-cell proliferation was 0.35 µg/g
Hg. The calculated ED50 for this response was
0.1 µg/g (y = –0.5244x3 – 2.1452x2 – 3.0577x
+ 0.482; r2 = 0.93).
Discussion
The use of blood to assess Hg exposure is an
attractive option for studies on both human
and wildlife health because blood can be non-
lethally collected and allows for the simulta-
neous determination of clinical parameters
that could be affected by Hg exposure. Blood
is also an economical matrix for analysis
because nearly all of the THg present in
blood is MeHg (Henny et al. 2002), reducing
the need for costly and time-consuming spe-
ciation. Therefore, the discussions of THg
exposure levels in vivo and MeHg exposures
in vitro are interchangeable for the purposes
required here. This study represents the ﬁrst
published research investigating the relation-
ship of Hg to health parameters in sea turtles.
Overall, the blood Hg concentrations
reported here are very similar to previous
ﬁndings from the same population (Table 1;
Day et al. 2005). Blood Hg concentrations in
this population are slightly higher than those
reported in loggerheads and Kemp’s ridleys
(Lepidochelys kempi) from the Gulf of Mexico
(Table 1) (Orvik 1997; Presti 1999; Wang
2003). Sea turtle blood Hg levels in general
are lower compared with those of most
marine mammals and seabirds, but the toxi-
cologic signiﬁcance of the blood Hg concen-
trations documented in most of these wildlife
species remains unclear.
The positive relationship observed between
blood Hg and hematocrit (Figure 2A) is con-
sistent with the role of red blood cells (RBCs)
as the primary transport mechanism of Hg
throughout the body. Depending on the
species, the cellular component of blood may
have Hg concentrations 10–200 times higher
than those of plasma because of the higher
afﬁnity of Hg for RBCs (Ansari et al. 1973;
Kershaw et al. 1980; Magos 1987; Suzuki
et al. 1971; U.S. EPA 1997). The Hg levels in
these two compartments attain a relatively
rapid equilibrium (Rabenstein et al. 1982,
1986), so the analysis of Hg in blood or
plasma separately could provide a value repre-
sentative of whole blood if a conversion factor
was established for the organism of interest
and the hematocrit was measured. In the
absence of this information, it may be useful
to analyze only RBCs for Hg, rather than
using whole blood. This approach allows for
an unbiased comparison among individuals
with a wide range of hematocrit without the
potential need for normalization, and also
eliminates the impact of incidental dilution
with other bodily ﬂuids (e.g., lymph) during
collection of the blood sample. Incidental col-
lection of lymph is not typically a problem
with sea turtles, but collecting blood from
smaller animals with much smaller vessels and
sinuses can prove more challenging. This
approach also makes more efﬁcient use of the
collected blood volume by using only the por-
tion of the blood where Hg is most concen-
trated, while leaving the plasma for other
clinical parameters or organic contaminant
analysis. This can be important when blood
volume is a limiting factor because of health
concerns or small body size, or when multiple
analyses are required.
If the hematocrit count is omitted from
the multiple regression analysis, the overall r2
and p-values for the model change from 0.54
to 0.34 (r2) and from 0.003 to 0.04 (p), and
CPK becomes the only parameter that is sig-
niﬁcant at α = 0.05. This demonstrates that
including this covariate in the statistical analy-
sis may have a beneﬁcial impact on data inter-
pretation, similar to using lipid-normalized
concentrations for highly lipophilic organic
contaminants. We observed this relationship
between Hg and hematocrit in spite of the
fact that most of the turtles in this sample set
were fairly healthy and relatively few had
hematocrit values far from the 36% that
would be considered normal (Maier et al.
2004). Studies that include compromised ani-
mals in fields such as wildlife toxicology,
heath assessments, or at rehabilitation centers
could encounter more variable hematocrit
counts and therefore an even greater potential
for confounding effects. For example, “sick”
loggerhead sea turtles captured in an abun-
dance survey had an average hematocrit of
23% compared with 36% in healthy animals
(Maier et al. 2004); in rehabilitation centers
that receive chronically ill sea turtles, the
hematocrit values are often < 10% (Norton
TM, unpublished data). As suggested by
Kershaw et al. (1980), if whole blood is ana-
lyzed for THg, hematocrit values should be
obtained to determine if this could be a
potential source of bias in the data.
CPK, an enzyme that is released into the
blood from certain tissues when cellular
damage occurs, is often used as an indicator
of tissue damage (Evans 1996). In verte-
brates, increased plasma CPK levels are typi-
cally associated with damage to skeletal
muscle, heart, brain, or lungs (Evans 1996).
The value of using CPK as an indicator of
altered sea turtle physiology is currently
unknown; however, if the interpretation in
this taxon is consistent with other verte-
brates, CPK levels suggest that individuals
with higher blood Hg levels exhibit greater
tissue damage. Based on mammalian studies,
determination of which particular CPK
Mercury and loggerhead sea turtle health
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Figure 3. Linear regression between the endoge-
nous blood Hg concentration (µg/g) and B-cell SI
for the nine individuals in the in vitro control group
for which Hg data were available. Samples were
stimulated with PDB and incubated for 120 hr, with
exposure to only the natural background Hg pre-
sent in the blood, making this in essence another
ex vivo proliferation assay. There was a highly sig-
nificant negative relationship (r2 = 0.80; p = 0.001)
across the natural range of Hg concentrations
measured in these animals (0.009–0.051 µg/g). 
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Table 3. Spearman rho correlation coefﬁcient and p-values for ex vivo lymphocyte proliferation, lysozyme
activity, and corticosterone versus total blood Hg concentration. 
Assay (mitogen) Mean ± SE No. Year Incubation (hr) ρ p-Value
T cell (Con A) 3.02 ± 0.08 13 2001 120 –0.15 0.649
T cell (Con A)  8.08 ± 2.56 10 2001 96 –0.07 0.865
B cell (LPS)  1.87 ± 0.32 12 2001 120 –0.27 0.391
B cell (LPS) 8.13 ± 10.24 9 2001 96 –0.03 0.932
B cell (PDB)a 4.28 ± 0.95 12 2001 120 –0.69 0.014
B cell (PDB) 2.82 ± 1.08 9 2001 96 –0.38 0.309
Lysozyme activitya,b  4.96 ± 0.60 12 2001 — 0.63  0.029
T cell (Con A)  36.24 ± 18.67 57 2003 120 –0.22 0.105
T cell (PHA) 115.70 ± 25.63 57 2003 120 –0.03 0.829
B cell (LPS) 2.17 ± 0.85 58 2003 96 0.06 0.642
B cell (PDB) 2.17 ± 0.55 58 2003 96 –0.08 0.544
B cell (PDB)a,c  0.66 ± 0.13  9 2003 120 –0.80  0.001
Lysozyme activity  11.02 ± 0.82 58 2003 — 0.12 0.388
Corticosterone 2.61 ± 0.39 37 2003 — 0.20 0.242
Mean values represent SI for lymphocyte proliferation, lysozyme activity (µg/µL HEL), and corticosterone (ng/mL). No
health parameters varied with either straight carapace length or sex, so all size classes and sexes were pooled for statisti-
cal analyses. Mean ± SE (range) of blood Hg concentration for samples collected in 2001 (n = 13) and 2003 (n = 58) were
0.037 ± 0.013 µg/g (0.012–0.188 µg/g) and 0.029 ± 0.002 µg/g (0.006–0.077 µg/g), respectively.
aParameters were statistically significant. bPearson correlation coefficient is reported for lysozyme activity versus log-
transformed Hg concentration, which showed a positive correlation. cThese data are from the control group from the
in vitro exposure; r2 and p-values are reported for a linear regression, which showed a negative relationship (Figure 3). isozyme is elevated would be necessary to
identify the organ with which the cell damage
is associated, or if any causal relationship with
Hg exposure exists. Although not statistically
signiﬁcant, studies in both coturnix quail and
European starlings fed Hg (HgCl or MeHg,
respectively) for 12 weeks have shown a trend
toward an increase in plasma CPK levels over
control (Dieter 1974, 1975). On the basis of
these previous studies, it is not unfounded
that CPK was increased in relation to blood
Hg in loggerhead turtles in the present study
(Figure 2B).
Elevation of the enzyme AST is another
indicator commonly used in clinical studies.
Although AST is most commonly used to
assess liver damage, it is also found in skeletal
muscle, heart, pancreas, and kidneys (Evans
1996). AST may become elevated in
response to various forms of stress in several
different taxa, and most of the literature
indicates that Hg exposure may also elevate
plasma AST levels (Adachi et al. 1996;
Hoffman et al. 2005). Relatively little is
known about the distribution and activity of
AST in sea turtles, but studies have found sea
turtles with fibropapillomatosis have either
elevated AST relative to disease-free animals
(Aguirre et al. 1995; Norton et al. 1990) or
no difference in AST (Swimmer 2000).
Positive correlations between concentrations
of AST and those of several organochlorine
contaminants have also been noted in the
plasma of loggerhead sea turtles (Keller et al.
2004). The health assessment effort that pro-
vided the samples in the present study found
comparable levels of plasma AST in healthy
and sick loggerhead sea turtles (Maier et al.
2004). Contradictory to what would be
expected based on the literature, in the pre-
sent study we found that turtles with higher
Hg had lower plasma AST levels. The impli-
cations of this negative correlation and the
diagnostic potential of AST in sea turtles are
currently unclear.
Few data are available on the effects of
chronic MeHg exposure on WBCs in
wildlife. Our results indicate that loggerheads
with higher blood Hg concentrations had
lower numbers of circulating lymphocytes
(Figure 2D). Thaxton et al. (1974) observed
a decrease in total WBC numbers in broiler
cockerels exposed to HgCl through drinking
water on posthatch days 1–42. This was pri-
marily due to a decrease in circulating num-
bers of lymphocytes and heterophils.
However, in a study in Kemp’s ridley sea tur-
tles, Peden-Adams et al. (2003) found no
correlation between blood Hg levels and total
WBC counts or WBC differential counts,
but they did report a negative relationship
between Hg levels in scutes and the number
of circulating eosinophils. Hg is known to
inhibit RNA and DNA synthesis and arrest
cell-cycle progression in B lymphocytes
(Daum et al. 1993). It is, therefore, plausible
that chronic low-level Hg exposure could
suppress the abundance of lymphocytes or
alter numbers of speciﬁc classes of WBCs. It
is important to note that with correlative ﬁeld
studies such as this, factors other than Hg
may be related to the aforementioned hema-
tologic changes. Further work is required to
confirm whether Hg is a causative factor in
the observed WBC count alterations.
Extensive work clearly shows Hg has
immunomodulatory effects on a variety of taxa
(Moszczynski 1997; Zelikoff et al. 1994).
Evidence suggests that Hg has immuno-
suppressive effects for most lymphocyte func-
tions, and this inhibition is often accompanied
by an increase in susceptibility to infectious
agents or tumor cells (Moszczynski 1997). For
example, exposure of mice to MeHg increased
their susceptibility to herpes virus (Christensen
et al. 1996; Ellermann-Eriksen et al. 1994).
The preliminary ex vivo proliferation
assessment performed in 2001 found a signiﬁ-
cant negative correlation between B-cell prolif-
eration and blood Hg concentration (n = 12)
but not T-cell proliferation. When the sample
size was subsequently expanded (n = 58) using
samples collected in 2003, no signiﬁcant corre-
lations were found between B-cell or T-cell
proliferations (Table 3). There are two possible
reasons for this inconsistency in the B-cell pro-
liferation results. First, the 2001 data had a
higher blood Hg concentration range and a
smaller overall sample size than the 2003
data. This may have increased the chances of
observing statistically signiﬁcant correlations
between Hg and lymphocyte proliferation in
the 2001 data because of stronger leveraging
by the individuals with high Hg levels that
subsequently showed the most notable corre-
lation. Second, in 2001, B-cell proliferation
(PDB-induced) correlated with THg only
after a 120-hr incubation (but not at 96 hr)
before the addition of tritium to the plates. In
2003 data, technical difﬁculties caused PDB-
induced proliferation to be available from the
96-hr incubation but not from the 120-hr
incubation.
The observed correlation in the 2001
ex vivo data prompted the in vitro MeHg
exposure experiments. Suppression of B-cell
proliferation was observed in vitro, corrobo-
rating the 2001 ex vivo results. In addition,
closer inspection of the in vitro data showed
another trend supporting the relationship
between B-cell proliferation and Hg: We
found a strong negative correlation between
B-cell proliferation and endogenous blood Hg
concentrations in the in vitro control samples.
The immunosuppressive response was
observed not only across the range of in vitro
dose levels (0–0.7 µg/g), but also across the
much smaller range of natural Hg concentra-
tions measured in animals within the control
treatment (0.009–0.051 µg/g) (Figure 3).
Like the 2001 ex vivo assays that showed sig-
nificant B-cell suppression, the incubation
time for the in vitro control was 120 hr. This
supports the hypothesis that nonoptimal assay
performance for the 2003 samples could have
explained the inconsistency discussed above.
This speaks to the sensitivity of the assay and
possibly to the sensitivity of the loggerhead sea
turtle immune system. Therefore, in future
in vitro assays, we recommend incorporating
the endogenous Hg concentrations of all indi-
viduals into the statistical model to account
for this potential source of variability within
dose groups.
Similarly, studies with Kemp’s ridley sea
turtles in relation to blood Hg levels showed
signiﬁcant negative correlations between Hg
Day et al.
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Figure 4. Loggerhead sea turtle lymphocyte proliferation following MeHg exposure. (A) Cell viability as measured with trypan blue (n = 8). (B) B-Cell proliferation
stimulated with PDB (n = 25). (C) T-Cell proliferation stimulated with PHA (n = 10). Data are presented as mean ± SE. Vertical lines in (B) and (C) indicate maximum/
minimum levels of total Hg previously measured in loggerhead sea turtle whole blood samples.
*Signiﬁcantly different from control (p < 0.05). 
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Cand T-cell proliferation (Peden-Adams et al.
2003). These effects in sea turtles occur at
substantially lower concentrations than
reported for other vertebrates, such as rats and
humans (Moszczynski 1997; Zelikoff et al.
1994). This is true even when accounting for
the presence of the endogenous Hg present in
addition to the dosed MeHg. This suggests
the sea turtle immune system may be more
sensitive to Hg toxicity. The concentrations
used in the in vitro exposure were selected
based on the range of blood Hg levels meas-
ured in wild animals (0.005–0.188 µg/g). Of
the 100 animals sampled from this popula-
tion, 5% had blood Hg levels above the
0.05-µg/g level that represents the highest
exposure with no observed effect. Therefore,
the in vitro experiment suggests that the por-
tion of the loggerhead population with the
highest Hg exposure could experience some
suppression of immune function.
Circulating lysozyme is a marker of pro-
inflammatory responses, has antibacterial
functions, and is a measure of innate immu-
nity (Burton et al. 2002; Weeks et al. 1992).
It is secreted by granulocytes upon entry of
foreign bacteria and lyses gram-positive bacte-
rial cells by degrading the cell wall (Balfry and
Iwama 2004; Ito et al. 1997). In ﬁsh, poly-
chlorinated biphenyls (PCBs) are known to
exhibit varied effects on lysozyme activity. For
example, female dab (Limanda limanda L.)
exposed for 7 days to sediments spiked with
PCBs showed no differences in serum
lysozyme activity (Hutchinson et al. 2003).
However, channel catﬁsh (Ictalurus punctatus)
exposed to PCB-126 (a planar PCB) exhibited
suppressed plasma lysozyme levels (Burton
et al. 2002). In loggerhead turtles 4,4´-DDE
(dichlorodiphenyltrichloroethylene) has been
shown to exhibit a negative relationship with
lysozyme activity (Keller et al. 2006b).
Baginski (1988) found that mercury chloride
exposure enhanced lysozyme release, which is
consistent with the signiﬁcant positive correla-
tion between lysozyme activity and blood Hg
concentration observed in the 2001 data.
However, we observed no correlation between
lysozyme and Hg in the 2003 study. As men-
tioned above, this could be related to the
smaller sample size and the presence of ani-
mals with the higher Hg concentrations
observed in the 2001 data set that drove the
observed trend.
The combined results from the correlative
ﬁeld study and the in vitro exposures suggest
that even low levels of Hg (relative to what is
found in other species) may relate to altered
health parameters in loggerhead sea turtles.
The overall health impact of the higher CPK,
lower lymphocyte counts, and suppressed
B-cell proliferation observed in the wild pop-
ulation is unclear. The captured loggerheads
all appeared to be in otherwise generally good
health based on a superﬁcial examination. In
the case of the leverage plots from the multi-
ple regressions (Figure 2), the considerable
variability in the health parameters relates to
blood Hg concentrations primarily at the
extreme ranges. Similarly, based on the con-
centration range used in the in vitro exposure,
approximately 5% of the wild population has
blood Hg levels that correspond to a signiﬁ-
cant decrease in lymphocyte proliferation
observed in vitro. Although the health
impacts of these trends could be considered
marginal, a moderate upward shift in the nat-
ural range of Hg exposures for these animals
could result in greater impacts at the popula-
tion level. Additionally, the ex vivo correla-
tions suggest an even higher sensitivity to Hg
immunomodulation. Few data are currently
available on blood Hg concentrations in sea
turtles from other regions. However, it is
likely that in areas such as Florida Bay and
the Indian River Lagoon (Florida), which
have elevated levels of environmental Hg
(Ache et al. 2000; Cantillo et al. 1999;
Trocine and Trefry 1996), there is also a
higher range of exposure for loggerheads and
other sea turtle species. Perhaps not by coin-
cidence, sea turtles in these areas also have an
unusually high incidence of the debilitating
and often fatal disease fibropapillomatosis.
Environmental stressors have been implicated
in the expression of ﬁbropapillomas, but no
work has currently been performed linking
Hg to the immunosuppression that is often
observed in individuals suffering from this
disease. To more thoroughly address the
potential impacts of Hg pollution on the
overall health and ﬁtness of these endangered
species, future work will target areas where
disease incidence and Hg levels are high.
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